PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Twin Research and Genetic Epidemiology, King\'s College London, London, United Kingdom.\', \'Clinical and Translational Epidemiology Unit and Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.\', \'Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.\', \'School of Biomedical Engineering & Imaging Sciences, King\'s College London, London, United Kingdom.\', \'Department of Clinical Sciences, Lund University, Malmö, Sweden.\', \'Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Sweden.\', \'Zoe Global Limited, London, United Kingdom.\', \'Department of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health. Boston, Massachusetts, USA.\', \'Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1634/theoncologist.2020-0572
?:hasPublicationType
?:journal
  • The oncologist
is ?:pmid of
?:pmid
?:pmid
  • 32845538
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Cancer and Risk of COVID-19 Through a General Community Survey.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all